Predictors of stroke in patients with impaired glucose tolerance: Results from the nateglinide and valsartan in impaired glucose tolerance outcomes research trial

Stroke

Volumn 44, Issue 9, 2013, Pages 2590-2593

  Preiss, David ^a   Giles, Thomas D ^b   Thomas, Laine E ^c   Sun, Jie Lena ^c   Haffner, Steven M ^d   Holman, Rury R ^e   Standl, Eberhard ^f   Mazzone, Theodore ^g   Rutten, Guy E ^h   Tognoni, Gianni ⁱ   Chiang, Fu Tien ^j   McMurray, John J V ^a   Califf, Robert M ^k  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f Helmholtz Centre   (Germany)

^g UNIVERSITY OF ILLINOIS   (United States)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ Consorzio Mario Negri Sud ^*  (Italy)

^j NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Impaired glucose tolerance; Stroke

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; NATEGLINIDE; VALSARTAN;

ADULT; AGED; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PULSE PRESSURE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENESCENCE; TRANSIENT ISCHEMIC ATTACK; WAIST CIRCUMFERENCE;

IMPAIRED GLUCOSE TOLERANCE; STROKE;

AGED; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; CONTROLLED CLINICAL TRIALS AS TOPIC; CYCLOHEXANES; DRUG THERAPY, COMBINATION; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHENYLALANINE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE; TETRAZOLES; VALINE;

EID: 84884490191     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001177     Document Type: Article

References (4)

1. Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010;55:1310-1317.
2. Laakso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis. 1998;(suppl 137):S65-S73.
3. Califf RM, Boolell M, Haffner SM, Bethel M, McMurray J, Duggal A, et al; NAVIGATOR Study Group. Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. Am Heart J. 2008;156:623-632.
4. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.